nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Naltrexone—alcohol dependence	0.233	0.382	CbGbCtD
Ticagrelor—ABCB1—Citalopram—alcohol dependence	0.155	0.253	CbGbCtD
Ticagrelor—CYP3A4—Disulfiram—alcohol dependence	0.13	0.213	CbGbCtD
Ticagrelor—CYP3A4—Citalopram—alcohol dependence	0.0926	0.152	CbGbCtD
Ticagrelor—Traumatic haematoma—Citalopram—alcohol dependence	0.0267	0.107	CcSEcCtD
Ticagrelor—Increased tendency to bruise—Citalopram—alcohol dependence	0.0104	0.0415	CcSEcCtD
Ticagrelor—Injection site haemorrhage—Naltrexone—alcohol dependence	0.00943	0.0376	CcSEcCtD
Ticagrelor—Blood urine present—Citalopram—alcohol dependence	0.00683	0.0272	CcSEcCtD
Ticagrelor—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.00638	0.0608	CbGpPWpGaD
Ticagrelor—P2RY12—forebrain—alcohol dependence	0.00524	0.156	CbGeAlD
Ticagrelor—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00509	0.0485	CbGpPWpGaD
Ticagrelor—Presyncope—Citalopram—alcohol dependence	0.00506	0.0202	CcSEcCtD
Ticagrelor—P2RY12—cardiovascular system—alcohol dependence	0.00443	0.132	CbGeAlD
Ticagrelor—Haematemesis—Acamprosate—alcohol dependence	0.00386	0.0154	CcSEcCtD
Ticagrelor—Metrorrhagia—Acamprosate—alcohol dependence	0.00376	0.015	CcSEcCtD
Ticagrelor—P2RY12—blood—alcohol dependence	0.0035	0.104	CbGeAlD
Ticagrelor—Eye haemorrhage—Citalopram—alcohol dependence	0.00343	0.0137	CcSEcCtD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00326	0.031	CbGpPWpGaD
Ticagrelor—Transient ischaemic attack—Citalopram—alcohol dependence	0.00319	0.0127	CcSEcCtD
Ticagrelor—P2RY12—endocrine gland—alcohol dependence	0.00304	0.0903	CbGeAlD
Ticagrelor—Rectal haemorrhage—Acamprosate—alcohol dependence	0.00297	0.0119	CcSEcCtD
Ticagrelor—Hyperuricaemia—Acamprosate—alcohol dependence	0.00289	0.0115	CcSEcCtD
Ticagrelor—Gout—Acamprosate—alcohol dependence	0.00288	0.0115	CcSEcCtD
Ticagrelor—P2RY12—nervous system—alcohol dependence	0.00284	0.0845	CbGeAlD
Ticagrelor—Gingival bleeding—Citalopram—alcohol dependence	0.00284	0.0113	CcSEcCtD
Ticagrelor—P2RY12—central nervous system—alcohol dependence	0.00274	0.0813	CbGeAlD
Ticagrelor—Blood uric acid increased—Acamprosate—alcohol dependence	0.00273	0.0109	CcSEcCtD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.0027	0.0257	CbGpPWpGaD
Ticagrelor—Melaena—Acamprosate—alcohol dependence	0.00262	0.0105	CcSEcCtD
Ticagrelor—Haematoma—Citalopram—alcohol dependence	0.00256	0.0102	CcSEcCtD
Ticagrelor—Ecchymosis—Acamprosate—alcohol dependence	0.00243	0.00968	CcSEcCtD
Ticagrelor—Haematemesis—Citalopram—alcohol dependence	0.00232	0.00924	CcSEcCtD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.0023	0.0219	CbGpPWpGaD
Ticagrelor—Metrorrhagia—Citalopram—alcohol dependence	0.00225	0.00898	CcSEcCtD
Ticagrelor—Vaginal haemorrhage—Citalopram—alcohol dependence	0.00217	0.00867	CcSEcCtD
Ticagrelor—P2RY12—brain—alcohol dependence	0.00217	0.0646	CbGeAlD
Ticagrelor—P2RY12—G alpha (i) signalling events—OPRK1—alcohol dependence	0.00215	0.0205	CbGpPWpGaD
Ticagrelor—Renal failure acute—Acamprosate—alcohol dependence	0.00211	0.00842	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00203	0.00811	CcSEcCtD
Ticagrelor—Cardiac failure—Acamprosate—alcohol dependence	0.002	0.00796	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00199	0.019	CbGpPWpGaD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00195	0.0186	CbGpPWpGaD
Ticagrelor—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00195	0.00777	CcSEcCtD
Ticagrelor—Atrial fibrillation—Naltrexone—alcohol dependence	0.00195	0.00776	CcSEcCtD
Ticagrelor—Contusion—Citalopram—alcohol dependence	0.00184	0.00736	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00184	0.00735	CcSEcCtD
Ticagrelor—Blood creatinine increased—Acamprosate—alcohol dependence	0.00183	0.00728	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00181	0.0172	CbGpPWpGaD
Ticagrelor—Bone disorder—Citalopram—alcohol dependence	0.00178	0.00711	CcSEcCtD
Ticagrelor—Rectal haemorrhage—Citalopram—alcohol dependence	0.00178	0.00711	CcSEcCtD
Ticagrelor—Breast disorder—Acamprosate—alcohol dependence	0.00176	0.00702	CcSEcCtD
Ticagrelor—Oliguria—Citalopram—alcohol dependence	0.00175	0.00696	CcSEcCtD
Ticagrelor—Paraesthesia—Disulfiram—alcohol dependence	0.00175	0.00696	CcSEcCtD
Ticagrelor—Gastritis—Acamprosate—alcohol dependence	0.00172	0.00688	CcSEcCtD
Ticagrelor—Gout—Citalopram—alcohol dependence	0.00172	0.00687	CcSEcCtD
Ticagrelor—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00172	0.0164	CbGpPWpGaD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00171	0.0163	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00171	0.0163	CbGpPWpGaD
Ticagrelor—Fatigue—Disulfiram—alcohol dependence	0.00168	0.00668	CcSEcCtD
Ticagrelor—Blood uric acid increased—Citalopram—alcohol dependence	0.00164	0.00654	CcSEcCtD
Ticagrelor—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00163	0.0155	CbGpPWpGaD
Ticagrelor—Melaena—Citalopram—alcohol dependence	0.00157	0.00627	CcSEcCtD
Ticagrelor—Ecchymosis—Citalopram—alcohol dependence	0.00146	0.0058	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—OPRD1—alcohol dependence	0.00144	0.0138	CbGpPWpGaD
Ticagrelor—Gynaecomastia—Citalopram—alcohol dependence	0.00144	0.00574	CcSEcCtD
Ticagrelor—Haematuria—Acamprosate—alcohol dependence	0.00143	0.00571	CcSEcCtD
Ticagrelor—Epistaxis—Acamprosate—alcohol dependence	0.00142	0.00565	CcSEcCtD
Ticagrelor—Asthenia—Disulfiram—alcohol dependence	0.0014	0.00556	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—PDYN—alcohol dependence	0.00138	0.0132	CbGpPWpGaD
Ticagrelor—Haemoglobin—Acamprosate—alcohol dependence	0.00136	0.0054	CcSEcCtD
Ticagrelor—Haemorrhage—Acamprosate—alcohol dependence	0.00135	0.00538	CcSEcCtD
Ticagrelor—Epistaxis—Naltrexone—alcohol dependence	0.00134	0.00534	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00134	0.0128	CbGpPWpGaD
Ticagrelor—Oedema peripheral—Acamprosate—alcohol dependence	0.00133	0.0053	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—OPRK1—alcohol dependence	0.0013	0.0124	CbGpPWpGaD
Ticagrelor—Dizziness—Disulfiram—alcohol dependence	0.00129	0.00513	CcSEcCtD
Ticagrelor—Renal failure acute—Citalopram—alcohol dependence	0.00127	0.00505	CcSEcCtD
Ticagrelor—Connective tissue disorder—Naltrexone—alcohol dependence	0.00125	0.005	CcSEcCtD
Ticagrelor—Atrial fibrillation—Citalopram—alcohol dependence	0.00123	0.00492	CcSEcCtD
Ticagrelor—Rash—Disulfiram—alcohol dependence	0.00123	0.00489	CcSEcCtD
Ticagrelor—Headache—Disulfiram—alcohol dependence	0.00122	0.00486	CcSEcCtD
Ticagrelor—Immune system disorder—Acamprosate—alcohol dependence	0.00122	0.00486	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CHRM2—alcohol dependence	0.00121	0.0115	CbGpPWpGaD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00121	0.0115	CbGpPWpGaD
Ticagrelor—Cardiac failure—Citalopram—alcohol dependence	0.0012	0.00477	CcSEcCtD
Ticagrelor—Eye disorder—Naltrexone—alcohol dependence	0.00119	0.00475	CcSEcCtD
Ticagrelor—Cardiac disorder—Naltrexone—alcohol dependence	0.00118	0.00472	CcSEcCtD
Ticagrelor—Mental disorder—Acamprosate—alcohol dependence	0.00118	0.00471	CcSEcCtD
Ticagrelor—Malnutrition—Acamprosate—alcohol dependence	0.00117	0.00468	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.00117	0.00466	CcSEcCtD
Ticagrelor—Angiopathy—Naltrexone—alcohol dependence	0.00116	0.00461	CcSEcCtD
Ticagrelor—Immune system disorder—Naltrexone—alcohol dependence	0.00115	0.00459	CcSEcCtD
Ticagrelor—Mediastinal disorder—Naltrexone—alcohol dependence	0.00115	0.00458	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00115	0.0109	CbGpPWpGaD
Ticagrelor—Back pain—Acamprosate—alcohol dependence	0.00114	0.00453	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00112	0.0107	CbGpPWpGaD
Ticagrelor—Mental disorder—Naltrexone—alcohol dependence	0.00112	0.00446	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—OPRM1—alcohol dependence	0.00111	0.0106	CbGpPWpGaD
Ticagrelor—Malnutrition—Naltrexone—alcohol dependence	0.00111	0.00443	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.0011	0.0105	CbGpPWpGaD
Ticagrelor—Back pain—Naltrexone—alcohol dependence	0.00107	0.00428	CcSEcCtD
Ticagrelor—Angioedema—Acamprosate—alcohol dependence	0.00107	0.00428	CcSEcCtD
Ticagrelor—Breast disorder—Citalopram—alcohol dependence	0.00106	0.00421	CcSEcCtD
Ticagrelor—Vertigo—Acamprosate—alcohol dependence	0.00105	0.0042	CcSEcCtD
Ticagrelor—Syncope—Acamprosate—alcohol dependence	0.00105	0.0042	CcSEcCtD
Ticagrelor—Gastritis—Citalopram—alcohol dependence	0.00103	0.00412	CcSEcCtD
Ticagrelor—Loss of consciousness—Acamprosate—alcohol dependence	0.00103	0.00411	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00103	0.00982	CbGpPWpGaD
Ticagrelor—Cough—Acamprosate—alcohol dependence	0.00102	0.00408	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—NPY—alcohol dependence	0.00102	0.00974	CbGpPWpGaD
Ticagrelor—Angioedema—Naltrexone—alcohol dependence	0.00101	0.00405	CcSEcCtD
Ticagrelor—Hypertension—Acamprosate—alcohol dependence	0.00101	0.00404	CcSEcCtD
Ticagrelor—Chest pain—Acamprosate—alcohol dependence	0.000999	0.00398	CcSEcCtD
Ticagrelor—Syncope—Naltrexone—alcohol dependence	0.000996	0.00397	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000992	0.00396	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—HTR1B—alcohol dependence	0.000986	0.0094	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Naltrexone—alcohol dependence	0.000976	0.00389	CcSEcCtD
Ticagrelor—Cough—Naltrexone—alcohol dependence	0.000969	0.00386	CcSEcCtD
Ticagrelor—Confusional state—Acamprosate—alcohol dependence	0.000966	0.00385	CcSEcCtD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000964	0.00919	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000962	0.00916	CbGpPWpGaD
Ticagrelor—Hypertension—Naltrexone—alcohol dependence	0.000959	0.00382	CcSEcCtD
Ticagrelor—Chest pain—Naltrexone—alcohol dependence	0.000945	0.00377	CcSEcCtD
Ticagrelor—Shock—Acamprosate—alcohol dependence	0.000942	0.00376	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000939	0.00374	CcSEcCtD
Ticagrelor—Skin disorder—Acamprosate—alcohol dependence	0.00093	0.00371	CcSEcCtD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000918	0.00874	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000915	0.00872	CbGpPWpGaD
Ticagrelor—Confusional state—Naltrexone—alcohol dependence	0.000914	0.00364	CcSEcCtD
Ticagrelor—Hypotension—Acamprosate—alcohol dependence	0.000895	0.00357	CcSEcCtD
Ticagrelor—Shock—Naltrexone—alcohol dependence	0.000892	0.00356	CcSEcCtD
Ticagrelor—Nervous system disorder—Naltrexone—alcohol dependence	0.000889	0.00354	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000883	0.00841	CbGpPWpGaD
Ticagrelor—Skin disorder—Naltrexone—alcohol dependence	0.00088	0.00351	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—OPRD1—alcohol dependence	0.000874	0.00833	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—DRD4—alcohol dependence	0.000862	0.00821	CbGpPWpGaD
Ticagrelor—Paraesthesia—Acamprosate—alcohol dependence	0.00086	0.00343	CcSEcCtD
Ticagrelor—Haematuria—Citalopram—alcohol dependence	0.000859	0.00342	CcSEcCtD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000857	0.00816	CbGpPWpGaD
Ticagrelor—Dyspnoea—Acamprosate—alcohol dependence	0.000854	0.00341	CcSEcCtD
Ticagrelor—Epistaxis—Citalopram—alcohol dependence	0.000849	0.00339	CcSEcCtD
Ticagrelor—Dyspepsia—Acamprosate—alcohol dependence	0.000843	0.00336	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—PDYN—alcohol dependence	0.000838	0.00798	CbGpPWpGaD
Ticagrelor—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000827	0.0033	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CNR1—alcohol dependence	0.000823	0.00784	CbGpPWpGaD
Ticagrelor—Bradycardia—Citalopram—alcohol dependence	0.000823	0.00328	CcSEcCtD
Ticagrelor—Constipation—Acamprosate—alcohol dependence	0.000819	0.00327	CcSEcCtD
Ticagrelor—Paraesthesia—Naltrexone—alcohol dependence	0.000814	0.00324	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000813	0.00774	CbGpPWpGaD
Ticagrelor—Haemoglobin—Citalopram—alcohol dependence	0.000812	0.00324	CcSEcCtD
Ticagrelor—Haemorrhage—Citalopram—alcohol dependence	0.000808	0.00322	CcSEcCtD
Ticagrelor—Dyspnoea—Naltrexone—alcohol dependence	0.000808	0.00322	CcSEcCtD
Ticagrelor—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000807	0.00768	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—DRD2—alcohol dependence	0.000803	0.00765	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.0008	0.00762	CbGpPWpGaD
Ticagrelor—Urinary tract disorder—Citalopram—alcohol dependence	0.000798	0.00318	CcSEcCtD
Ticagrelor—Oedema peripheral—Citalopram—alcohol dependence	0.000796	0.00317	CcSEcCtD
Ticagrelor—Connective tissue disorder—Citalopram—alcohol dependence	0.000794	0.00317	CcSEcCtD
Ticagrelor—Urethral disorder—Citalopram—alcohol dependence	0.000792	0.00316	CcSEcCtD
Ticagrelor—Feeling abnormal—Acamprosate—alcohol dependence	0.000789	0.00315	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000784	0.00747	CbGpPWpGaD
Ticagrelor—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000783	0.00312	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000782	0.00312	CcSEcCtD
Ticagrelor—Fatigue—Naltrexone—alcohol dependence	0.000781	0.00312	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CRHR1—alcohol dependence	0.000779	0.00742	CbGpPWpGaD
Ticagrelor—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000776	0.00739	CbGpPWpGaD
Ticagrelor—Constipation—Naltrexone—alcohol dependence	0.000775	0.00309	CcSEcCtD
Ticagrelor—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000772	0.00735	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000764	0.00728	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000761	0.00724	CbGpPWpGaD
Ticagrelor—Body temperature increased—Acamprosate—alcohol dependence	0.000757	0.00302	CcSEcCtD
Ticagrelor—Abdominal pain—Acamprosate—alcohol dependence	0.000757	0.00302	CcSEcCtD
Ticagrelor—Eye disorder—Citalopram—alcohol dependence	0.000755	0.00301	CcSEcCtD
Ticagrelor—Cardiac disorder—Citalopram—alcohol dependence	0.00075	0.00299	CcSEcCtD
Ticagrelor—Feeling abnormal—Naltrexone—alcohol dependence	0.000747	0.00298	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000745	0.0071	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000745	0.0071	CbGpPWpGaD
Ticagrelor—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000741	0.00295	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—OPRK1—alcohol dependence	0.000735	0.007	CbGpPWpGaD
Ticagrelor—Angiopathy—Citalopram—alcohol dependence	0.000733	0.00292	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CHRM2—alcohol dependence	0.000733	0.00698	CbGpPWpGaD
Ticagrelor—Immune system disorder—Citalopram—alcohol dependence	0.00073	0.00291	CcSEcCtD
Ticagrelor—Mediastinal disorder—Citalopram—alcohol dependence	0.000728	0.0029	CcSEcCtD
Ticagrelor—Body temperature increased—Naltrexone—alcohol dependence	0.000716	0.00286	CcSEcCtD
Ticagrelor—Abdominal pain—Naltrexone—alcohol dependence	0.000716	0.00286	CcSEcCtD
Ticagrelor—Mental disorder—Citalopram—alcohol dependence	0.000708	0.00282	CcSEcCtD
Ticagrelor—Hypersensitivity—Acamprosate—alcohol dependence	0.000706	0.00281	CcSEcCtD
Ticagrelor—Malnutrition—Citalopram—alcohol dependence	0.000704	0.00281	CcSEcCtD
Ticagrelor—Asthenia—Acamprosate—alcohol dependence	0.000687	0.00274	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000686	0.00653	CbGpPWpGaD
Ticagrelor—Back pain—Citalopram—alcohol dependence	0.000681	0.00271	CcSEcCtD
Ticagrelor—Pruritus—Acamprosate—alcohol dependence	0.000678	0.0027	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—OPRM1—alcohol dependence	0.000673	0.00641	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Naltrexone—alcohol dependence	0.000668	0.00266	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—OPRK1—alcohol dependence	0.000668	0.00636	CbGpPWpGaD
Ticagrelor—Diarrhoea—Acamprosate—alcohol dependence	0.000655	0.00261	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000655	0.00623	CbGpPWpGaD
Ticagrelor—Asthenia—Naltrexone—alcohol dependence	0.00065	0.00259	CcSEcCtD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000647	0.00616	CbGpPWpGaD
Ticagrelor—ABCB1—forebrain—alcohol dependence	0.000644	0.0192	CbGeAlD
Ticagrelor—Angioedema—Citalopram—alcohol dependence	0.000643	0.00256	CcSEcCtD
Ticagrelor—Pruritus—Naltrexone—alcohol dependence	0.000641	0.00256	CcSEcCtD
Ticagrelor—CYP3A4—digestive system—alcohol dependence	0.000639	0.019	CbGeAlD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000639	0.00608	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000639	0.00608	CbGpPWpGaD
Ticagrelor—Dizziness—Acamprosate—alcohol dependence	0.000633	0.00253	CcSEcCtD
Ticagrelor—Vertigo—Citalopram—alcohol dependence	0.000632	0.00252	CcSEcCtD
Ticagrelor—Syncope—Citalopram—alcohol dependence	0.000631	0.00252	CcSEcCtD
Ticagrelor—Diarrhoea—Naltrexone—alcohol dependence	0.00062	0.00247	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—NPY—alcohol dependence	0.000619	0.0059	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Citalopram—alcohol dependence	0.000618	0.00247	CcSEcCtD
Ticagrelor—Cough—Citalopram—alcohol dependence	0.000614	0.00245	CcSEcCtD
Ticagrelor—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.00061	0.00581	CbGpPWpGaD
Ticagrelor—Vomiting—Acamprosate—alcohol dependence	0.000609	0.00243	CcSEcCtD
Ticagrelor—CYP3A4—blood—alcohol dependence	0.000609	0.0181	CbGeAlD
Ticagrelor—Hypertension—Citalopram—alcohol dependence	0.000608	0.00242	CcSEcCtD
Ticagrelor—Rash—Acamprosate—alcohol dependence	0.000604	0.00241	CcSEcCtD
Ticagrelor—Dermatitis—Acamprosate—alcohol dependence	0.000603	0.00241	CcSEcCtD
Ticagrelor—Headache—Acamprosate—alcohol dependence	0.0006	0.00239	CcSEcCtD
Ticagrelor—Dizziness—Naltrexone—alcohol dependence	0.000599	0.00239	CcSEcCtD
Ticagrelor—Chest pain—Citalopram—alcohol dependence	0.000599	0.00239	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—HTR1B—alcohol dependence	0.000597	0.00569	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CRH—alcohol dependence	0.000597	0.00569	CbGpPWpGaD
Ticagrelor—ABCB1—adrenal cortex—alcohol dependence	0.000597	0.0177	CbGeAlD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000595	0.00237	CcSEcCtD
Ticagrelor—Confusional state—Citalopram—alcohol dependence	0.000579	0.00231	CcSEcCtD
Ticagrelor—Vomiting—Naltrexone—alcohol dependence	0.000576	0.0023	CcSEcCtD
Ticagrelor—Rash—Naltrexone—alcohol dependence	0.000571	0.00228	CcSEcCtD
Ticagrelor—Dermatitis—Naltrexone—alcohol dependence	0.000571	0.00228	CcSEcCtD
Ticagrelor—Nausea—Acamprosate—alcohol dependence	0.000569	0.00227	CcSEcCtD
Ticagrelor—Headache—Naltrexone—alcohol dependence	0.000568	0.00226	CcSEcCtD
Ticagrelor—Shock—Citalopram—alcohol dependence	0.000565	0.00225	CcSEcCtD
Ticagrelor—Nervous system disorder—Citalopram—alcohol dependence	0.000563	0.00225	CcSEcCtD
Ticagrelor—Skin disorder—Citalopram—alcohol dependence	0.000558	0.00222	CcSEcCtD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00055	0.00524	CbGpPWpGaD
Ticagrelor—ABCB1—cardiovascular system—alcohol dependence	0.000545	0.0162	CbGeAlD
Ticagrelor—Nausea—Naltrexone—alcohol dependence	0.000538	0.00215	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000538	0.00512	CbGpPWpGaD
Ticagrelor—Hypotension—Citalopram—alcohol dependence	0.000537	0.00214	CcSEcCtD
Ticagrelor—ABCB1—pancreas—alcohol dependence	0.000529	0.0157	CbGeAlD
Ticagrelor—CYP3A4—endocrine gland—alcohol dependence	0.000528	0.0157	CbGeAlD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000528	0.00503	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000522	0.00497	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD4—alcohol dependence	0.000522	0.00497	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000518	0.00494	CbGpPWpGaD
Ticagrelor—Paraesthesia—Citalopram—alcohol dependence	0.000516	0.00206	CcSEcCtD
Ticagrelor—Dyspnoea—Citalopram—alcohol dependence	0.000512	0.00204	CcSEcCtD
Ticagrelor—Dyspepsia—Citalopram—alcohol dependence	0.000506	0.00202	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CNR1—alcohol dependence	0.000498	0.00475	CbGpPWpGaD
Ticagrelor—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000496	0.00198	CcSEcCtD
Ticagrelor—Fatigue—Citalopram—alcohol dependence	0.000495	0.00197	CcSEcCtD
Ticagrelor—ABCB1—gonad—alcohol dependence	0.000494	0.0147	CbGeAlD
Ticagrelor—P2RY12—GPCR downstream signaling—OPRD1—alcohol dependence	0.000494	0.00471	CbGpPWpGaD
Ticagrelor—CYP3A4—nervous system—alcohol dependence	0.000494	0.0147	CbGeAlD
Ticagrelor—Constipation—Citalopram—alcohol dependence	0.000491	0.00196	CcSEcCtD
Ticagrelor—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000488	0.00464	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD2—alcohol dependence	0.000486	0.00463	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HTR7—alcohol dependence	0.000486	0.00463	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000482	0.00459	CbGpPWpGaD
Ticagrelor—CYP3A4—liver—alcohol dependence	0.000476	0.0141	CbGeAlD
Ticagrelor—CYP3A4—central nervous system—alcohol dependence	0.000476	0.0141	CbGeAlD
Ticagrelor—P2RY12—GPCR downstream signaling—PDYN—alcohol dependence	0.000474	0.00451	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Citalopram—alcohol dependence	0.000473	0.00189	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Citalopram—alcohol dependence	0.00047	0.00187	CcSEcCtD
Ticagrelor—Body temperature increased—Citalopram—alcohol dependence	0.000454	0.00181	CcSEcCtD
Ticagrelor—Abdominal pain—Citalopram—alcohol dependence	0.000454	0.00181	CcSEcCtD
Ticagrelor—ABCB1—digestive system—alcohol dependence	0.000452	0.0134	CbGeAlD
Ticagrelor—P2RY12—G alpha (i) signalling events—POMC—alcohol dependence	0.000449	0.00428	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—OPRD1—alcohol dependence	0.000449	0.00427	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000447	0.00426	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CRHR1—alcohol dependence	0.00044	0.00419	CbGpPWpGaD
Ticagrelor—ABCB1—blood—alcohol dependence	0.000431	0.0128	CbGeAlD
Ticagrelor—P2RY12—Signaling by GPCR—PDYN—alcohol dependence	0.00043	0.0041	CbGpPWpGaD
Ticagrelor—ABCB1—midbrain—alcohol dependence	0.000425	0.0126	CbGeAlD
Ticagrelor—Hypersensitivity—Citalopram—alcohol dependence	0.000423	0.00169	CcSEcCtD
Ticagrelor—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000414	0.00395	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CHRM2—alcohol dependence	0.000414	0.00394	CbGpPWpGaD
Ticagrelor—Asthenia—Citalopram—alcohol dependence	0.000412	0.00164	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—AVP—alcohol dependence	0.000409	0.0039	CbGpPWpGaD
Ticagrelor—Pruritus—Citalopram—alcohol dependence	0.000406	0.00162	CcSEcCtD
Ticagrelor—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000404	0.00385	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CRHR1—alcohol dependence	0.0004	0.00381	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0004	0.00381	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—OPRK1—alcohol dependence	0.000394	0.00376	CbGpPWpGaD
Ticagrelor—Diarrhoea—Citalopram—alcohol dependence	0.000393	0.00157	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—OPRM1—alcohol dependence	0.00038	0.00362	CbGpPWpGaD
Ticagrelor—Dizziness—Citalopram—alcohol dependence	0.00038	0.00151	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CHRM2—alcohol dependence	0.000376	0.00358	CbGpPWpGaD
Ticagrelor—ABCB1—endocrine gland—alcohol dependence	0.000374	0.0111	CbGeAlD
Ticagrelor—Vomiting—Citalopram—alcohol dependence	0.000365	0.00146	CcSEcCtD
Ticagrelor—Rash—Citalopram—alcohol dependence	0.000362	0.00144	CcSEcCtD
Ticagrelor—Dermatitis—Citalopram—alcohol dependence	0.000362	0.00144	CcSEcCtD
Ticagrelor—Headache—Citalopram—alcohol dependence	0.00036	0.00143	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000357	0.0034	CbGpPWpGaD
Ticagrelor—ABCB1—testis—alcohol dependence	0.000356	0.0106	CbGeAlD
Ticagrelor—P2RY12—GPCR downstream signaling—NPY—alcohol dependence	0.00035	0.00333	CbGpPWpGaD
Ticagrelor—ABCB1—nervous system—alcohol dependence	0.00035	0.0104	CbGeAlD
Ticagrelor—P2RY12—Signaling by GPCR—OPRM1—alcohol dependence	0.000345	0.00329	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000344	0.00327	CbGpPWpGaD
Ticagrelor—Nausea—Citalopram—alcohol dependence	0.000341	0.00136	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—HTR2A—alcohol dependence	0.000341	0.00324	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00034	0.00324	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CRH—alcohol dependence	0.000338	0.00321	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR1B—alcohol dependence	0.000338	0.00321	CbGpPWpGaD
Ticagrelor—ABCB1—liver—alcohol dependence	0.000337	0.01	CbGeAlD
Ticagrelor—ABCB1—central nervous system—alcohol dependence	0.000337	0.01	CbGeAlD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000335	0.00319	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000331	0.00315	CbGpPWpGaD
Ticagrelor—ABCB1—cerebellum—alcohol dependence	0.000329	0.00978	CbGeAlD
Ticagrelor—P2RY12—Signaling by GPCR—NPY—alcohol dependence	0.000318	0.00303	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR1B—alcohol dependence	0.000306	0.00292	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CRH—alcohol dependence	0.000306	0.00292	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD4—alcohol dependence	0.000295	0.00281	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000292	0.00278	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CNR1—alcohol dependence	0.000282	0.00268	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.00028	0.00267	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD2—alcohol dependence	0.000275	0.00262	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR7—alcohol dependence	0.000275	0.00262	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—POMC—alcohol dependence	0.000272	0.00259	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000272	0.00259	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD4—alcohol dependence	0.000268	0.00255	CbGpPWpGaD
Ticagrelor—ABCB1—brain—alcohol dependence	0.000267	0.00795	CbGeAlD
Ticagrelor—P2RY12—Signaling Pathways—OPRD1—alcohol dependence	0.000265	0.00252	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000256	0.00244	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CNR1—alcohol dependence	0.000256	0.00244	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDYN—alcohol dependence	0.000254	0.00242	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD2—alcohol dependence	0.00025	0.00238	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR7—alcohol dependence	0.00025	0.00238	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CRHR1—alcohol dependence	0.000236	0.00225	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—WASF2—alcohol dependence	0.000236	0.00225	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AVP—alcohol dependence	0.000231	0.0022	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—WASF1—alcohol dependence	0.000226	0.00216	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000223	0.00213	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CHRM2—alcohol dependence	0.000222	0.00212	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000212	0.00202	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AVP—alcohol dependence	0.00021	0.002	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—OPRM1—alcohol dependence	0.000204	0.00194	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR2A—alcohol dependence	0.000192	0.00183	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NPY—alcohol dependence	0.000188	0.00179	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR1B—alcohol dependence	0.000181	0.00172	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CRH—alcohol dependence	0.000181	0.00172	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.00018	0.00172	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000179	0.00171	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000179	0.00171	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR2A—alcohol dependence	0.000175	0.00166	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000173	0.00165	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—EP300—alcohol dependence	0.000161	0.00154	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD4—alcohol dependence	0.000158	0.00151	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—alcohol dependence	0.000154	0.00146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CNR1—alcohol dependence	0.000151	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD2—alcohol dependence	0.000147	0.0014	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR7—alcohol dependence	0.000147	0.0014	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000147	0.0014	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000145	0.00139	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000144	0.00137	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000142	0.00136	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—alcohol dependence	0.00014	0.00133	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADH6—alcohol dependence	0.000135	0.00129	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000132	0.00126	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AVP—alcohol dependence	0.000124	0.00118	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000119	0.00113	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADH1A—alcohol dependence	0.000112	0.00107	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR2A—alcohol dependence	0.000103	0.000984	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADH4—alcohol dependence	9.54e-05	0.000908	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADH6—alcohol dependence	8.34e-05	0.000794	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	8.33e-05	0.000794	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—alcohol dependence	8.25e-05	0.000785	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADH7—alcohol dependence	8.11e-05	0.000772	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GGT2—alcohol dependence	7.77e-05	0.00074	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—alcohol dependence	7.73e-05	0.000736	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	7.65e-05	0.000729	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADH1B—alcohol dependence	7.11e-05	0.000677	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.91e-05	0.000658	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	6.89e-05	0.000656	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MAOB—alcohol dependence	5.89e-05	0.000561	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADH4—alcohol dependence	5.87e-05	0.00056	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EP300—alcohol dependence	5.47e-05	0.000521	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH2—alcohol dependence	5.01e-05	0.000477	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADH7—alcohol dependence	5e-05	0.000476	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GGT2—alcohol dependence	4.79e-05	0.000456	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.38e-05	0.000417	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GOT2—alcohol dependence	4.26e-05	0.000406	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2E1—alcohol dependence	4e-05	0.000381	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GGT1—alcohol dependence	3.68e-05	0.00035	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GOT1—alcohol dependence	3.68e-05	0.00035	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MAOB—alcohol dependence	3.63e-05	0.000346	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MAOA—alcohol dependence	3.29e-05	0.000314	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.09e-05	0.000294	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GOT2—alcohol dependence	2.62e-05	0.00025	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.47e-05	0.000235	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GOT1—alcohol dependence	2.27e-05	0.000216	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GGT1—alcohol dependence	2.27e-05	0.000216	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—alcohol dependence	2.14e-05	0.000204	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MAOA—alcohol dependence	2.03e-05	0.000193	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—EP300—alcohol dependence	1.42e-05	0.000136	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—alcohol dependence	1.32e-05	0.000126	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—EP300—alcohol dependence	8.77e-06	8.35e-05	CbGpPWpGaD
